Polycystic ovary syndrome (PCOS) is a complex hormonal condition affecting an estimated eight to 20 percent of women of ...

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.

Novo Nordisk said Friday it will replace its CEO, citing a sharp tumble for Novo shares amid growing competition.

Lars Fruergaard Jørgensen will step down after eight years helming the Danish drugmaker, shares of which have lost more than half their value over the past 12 months.

The question of dose is at play almost every time “is it true?” arises. Especially when it comes to carcinogenicity.